Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Hepatocellular Cancer”

514 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 514 results

Not applicableLooking for participantsNCT06349642
What this trial is testing

Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform

Who this might be right for
Early Stage Triple-Negative Breast CarcinomaMetastatic Bladder Urothelial CarcinomaMetastatic Cervical Carcinoma+24 more
Mayo Clinic 324
Early research (Phase 1)Study completedNCT00002854
What this trial is testing

High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
City of Hope Medical Center 33
Testing effectiveness (Phase 2)Study completedNCT00881751
What this trial is testing

Bevacizumab and Erlotinib or Sorafenib as First-Line Therapy in Treating Patients With Advanced Liver Cancer

Who this might be right for
Liver Cancer
Medical University of South Carolina 95
Not applicableUnknownNCT01924624
What this trial is testing

Adjuvant Therapy With Thalidomide After Curative Resection of Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaRecurrence
The First Affiliated Hospital of Xiamen University 140
Early research (Phase 1)Study completedNCT00101270
What this trial is testing

Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas

Who this might be right for
Childhood Burkitt LymphomaChildhood Central Nervous System Germ Cell TumorChildhood Diffuse Large Cell Lymphoma+26 more
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07515469
What this trial is testing

A Prospective, Single-Arm, Exploratory Study of the Safety and Efficacy of Neoadjuvant Treatment With QL1706, an Anti-PD-1/Anti-CTLA-4 Bispecific Antibody, in Resectable Stage IB and IIA Hepatocellular Carcinoma With High Recurrence Risk

Who this might be right for
HCC - Hepatocellular CarcinomaIparomlimab and Tuvonralimab InjectionNeoadjuvant Immunotherapy
Tianjin Medical University Cancer Institute and Hospital 30
Not applicableStudy completedNCT01963429
What this trial is testing

Comparison Between Radiofrequency Ablation and Hypofractionated Proton Beam Radiation for Recurrent/Residual HCC

Who this might be right for
Recurrent Small Hepatocellular CarcinomaResidual Small Hepatocellular Carcinoma
National Cancer Center, Korea 144
Large-scale testing (Phase 3)Study completedNCT04047173
What this trial is testing

RFA Versus SBRT for Recurrent Small HCC

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 166
Not applicableEnded earlyNCT02748304
What this trial is testing

Sorafenib Combined With Aspirin to Prevent the Recurrence in High-risk Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Fudan University 52
Not applicableStudy completedNCT02643173
What this trial is testing

Hepatocellular Carcinoma Recurrence and Anesthesia

Who this might be right for
Hepatocellular Carcinoma
Seoul National University Bundang Hospital 259
Testing effectiveness (Phase 2)UnknownNCT05161143
What this trial is testing

Donafenib Combined With TACE as Adjuvant Therapy of Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Peking Union Medical College Hospital 30
Early research (Phase 1)UnknownNCT03966209
What this trial is testing

Safety and Efficacy of PD-1 Inhibitors in Patients With Liver Transplant

Who this might be right for
Hepatocellular CarcinomaLiver Transplantation
Shanghai Zhongshan Hospital 20
Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Large-scale testing (Phase 3)Study completedNCT02788526
What this trial is testing

Adjuvant TACE to Reduce the HCC Recurrence After Resection

Who this might be right for
Carcinoma, Hepatocellular
Sun Yat-sen University 180
Large-scale testing (Phase 3)UnknownNCT03192644
What this trial is testing

The Impact on Recurrence Risk of Adjuvant Transarterial Chemoinfusion (TAI) Versus Adjuvant Transarterial Chemoembolization (TACE) for Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombosis (PVTT) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial.

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 162
Testing effectiveness (Phase 2)Ended earlyNCT03945799
What this trial is testing

Study of Anlotinib in Hepatocellular Carcinoma (HCC) Patients at High Risk of Post Surgery Recurrence

Who this might be right for
Hepatocellular Carcinoma
Zhejiang University 28
Testing effectiveness (Phase 2)Study completedNCT00002655
What this trial is testing

Cryosurgery in Treating Patients With Liver Cancer or Liver Metastases

Who this might be right for
Liver CancerMetastatic Cancer
University of Colorado, Denver
Testing effectiveness (Phase 2)UnknownNCT02426450
What this trial is testing

RFA Combined With Oxaliplatin + 5-FluoroUracil/LeucoVorin (5-FU/LV) (FOLFOX4) for Recurrent HCC

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 28
Testing effectiveness (Phase 2)Study completedNCT00019760
What this trial is testing

Isolated Hepatic Perfusion With Melphalan Followed By Chemotherapy in Treating Patients With Unresectable Colorectal Cancer That is Metastatic to the Liver

Who this might be right for
Recurrent Colon CancerLiver MetastasesStage IV Rectal Cancer+2 more
National Institutes of Health Clinical Center (CC)
Not applicableActive Not RecruitingNCT02119065
What this trial is testing

Pilot Study to Assess Lung Shunting of Yttrium-90 Microspheres Using PET/CT

Who this might be right for
Advanced Adult Primary Liver CancerLiver MetastasesLocalized Unresectable Adult Primary Liver Cancer+1 more
University of Cincinnati 6
Load More Results